Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Investment analysts at Zacks Research issued their FY2028 earnings per share (EPS) estimates for shares of Bio-Rad Laboratories in a report released on Monday, March 2nd. Zacks Research analyst Team forecasts that the medical research company wil